11
2018
Transportation service news
In 2011, 87 Black graduates of Howard University applied to medical school. And, Xavier University in New Orleans had 68 Black graduates who applied to U.S. medical schools according to the Association of American Medical Colleges. These schools were the leading suppliers of US black doctor talent but you can see there's not that many of us entering the grid, no matter what Shonda Rhimes wants you to believe about her
Grey's Anatomy TV show.Software that locates a black doctor isn't needed in Boston. That's because each Black Boston neighborhood has clinics located at gateway positions. In Roxbury, there's the Whittier Street Health Center, 1125 Tremont St, Roxbury Crossing, MA 02120, (617) 427-1000.
Dorchester and Jamaica Plain residents can count on the stable Harvard Health Care Clinic at the intersection of Franklin Park, Blue Hill Avenue and Columbia Road. Codman Square has the Codman Square Health Center, Mattapan has the Mattapan Community Health Clinic - the newest of them all.
Recent News
Touch 106 FM had a kidney specialist on the TMS show. During the broadcast it was stated that there are 5,000 people in Massachusetts who have End Stage Renal Failure and 2,270 were awaiting a kidney transplant in the year 2011.
NxSTAGE-a Waltham-based manufacturer of home kidney dialysis machines is experiencing fast growth. It was named the 10th fastest growing company in the nation by industry analyst and word is that they are giving Fresnius and Davita, the German and Warren Buffet owned kidney dialysis treatment facilities in Massachusetts - some competition. NxSTage is planning to open local kidney dialysis centers because demand for home dialysis is growing in leaps and bounds. NxStage provides the machines and supplies. It competes against BAXTER in the ancillary supply business. The Boston Business Journal has reported that NxStage hired 200 extra employees last year and plans to increase hiring worldwide through 2014 and 2015.
Hypertension and Diabetes is causing more and more Americans to suffer from Kidney disease. Predicting a 22% increase in diagnosed patients going forward, its evident that too many people are simply not getting to the doctor earlier enough to prevent kidney failure.
Multiple MyelomaThe cancer drug VELCADE, a popular prescribed component in the RVD regime ( Revilmid, Velcade, Dexamethasone ) applied to multiple myeloma patients scored a big win. The U.S. Food and Drug Administration (FDA) has approved VELCADE® (bortezomib) for the retreatment of adult patients with multiple myeloma (MM) who had previously responded to VELCADE therapy and relapsed at least six months following completion of prior VELCADE treatment. The labeling update includes dosing guidelines as well as safety and efficacy findings for the use of VELCADE as a single agent or VELCADE in combination with dexamethasone in patients previously treated with VELCADE.
view full article.
future highlights
placeholder
